About Glenmark Pharmaceuticals Limited (GLENMARK)
Glenmark Pharmaceuticals Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector.
GLENMARK trades on the Indian stock exchanges (NSE/BSE) and is classified as a large-cap stock .
Key Statistics
- Current Price
- ₹2,298.70
- Market Cap
- ₹648.75B
- 52-Week High
- ₹2,537.60
- 52-Week Low
- ₹1,801.40
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
₹1,000 Invested in Glenmark Pharmaceuticals Limited (GLENMARK)
How much would ₹1,000 invested in GLENMARK be worth today?
What would ₹1,000 invested in GLENMARK 1 year ago be worth today?
A ₹1,000 investment in Glenmark Pharmaceuticals Limited (GLENMARK) in 2025 would be worth ₹1,265 as of November 2026, representing a +26.5% total return.
What would ₹1,000 invested in GLENMARK 3 years ago be worth today?
A ₹1,000 investment in Glenmark Pharmaceuticals Limited (GLENMARK) in 2023 would be worth ₹2,945 as of November 2026, representing a +194.5% total return.
What would ₹1,000 invested in GLENMARK 5 years ago be worth today?
A ₹1,000 investment in Glenmark Pharmaceuticals Limited (GLENMARK) in 2021 would be worth ₹4,630 as of November 2026, representing a +363.0% total return.
What would ₹1,000 invested in GLENMARK 10 years ago be worth today?
A ₹1,000 investment in Glenmark Pharmaceuticals Limited (GLENMARK) in 2016 would be worth ₹2,734 as of November 2026, representing a +173.4% total return.
What would ₹1,000 invested in GLENMARK at IPO be worth today?
A ₹1,000 investment in Glenmark Pharmaceuticals Limited (GLENMARK) at IPO would be worth ₹7,817,636 as of November 2026, representing a +781663.6% total return.
Monthly Returns Heatmap
Over the past 24+ years (291 months), Glenmark Pharmaceuticals Limited (GLENMARK) has averaged a monthly return of +5.27% with a median return of +1.79%. The stock had 169 positive months (58%) and 122 negative months (42%). The best month in GLENMARK's history was October 2003 with a +449.9% return, while the worst was January 2009 at -53.6%. Historically, October tends to be the strongest month (averaging +17.5%), and January the weakest (-6.5%).
GLENMARK's longest winning streak was 10 consecutive months of gains, while its longest losing streak was 8 consecutive months of losses. The best full year was 2003 with a cumulative return of +686.6%, and the worst was 2019 at -62.2%.
Annual Returns
Over 24 years of trading history, Glenmark Pharmaceuticals Limited (GLENMARK) has delivered an average annual return of +159.22% with a median return of +23.36%. The compound annual growth rate (CAGR) is +41.65%. The stock posted gains in 17 years (71%) and losses in 7 years (29%).
GLENMARK's best year was 2003 with a +2854.36% gain, while the worst was 2008 at -50.32%. The longest streak of consecutive positive years was 5, and the longest losing streak was 2 years. GLENMARK achieved double-digit gains (10%+) in 15 years. It suffered double-digit losses in 5 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +13.06% | ₹2,033.18 | ₹2,298.70 |
| 2025 | +26.79% | ₹1,603.57 | ₹2,033.18 |
| 2024 | +88.70% | ₹849.80 | ₹1,603.57 |
| 2023 | +101.92% | ₹420.86 | ₹849.80 |
| 2022 | -19.23% | ₹521.07 | ₹420.86 |
| 2021 | +7.61% | ₹484.23 | ₹521.07 |
| 2020 | +42.75% | ₹339.22 | ₹484.23 |
| 2019 | -49.59% | ₹672.90 | ₹339.22 |
| 2018 | +16.87% | ₹575.76 | ₹672.90 |
| 2017 | -32.84% | ₹857.28 | ₹575.76 |
| 2016 | -3.40% | ₹887.45 | ₹857.28 |
| 2015 | +19.93% | ₹739.96 | ₹887.45 |
| 2014 | +44.79% | ₹511.07 | ₹739.96 |
| 2013 | +1.34% | ₹504.29 | ₹511.07 |
| 2012 | +81.01% | ₹278.60 | ₹504.29 |
| 2011 | -18.84% | ₹343.26 | ₹278.60 |
| 2010 | +31.45% | ₹261.13 | ₹343.26 |
| 2009 | -6.67% | ₹279.81 | ₹261.13 |
| 2008 | -50.32% | ₹563.20 | ₹279.81 |
| 2007 | +297.17% | ₹141.80 | ₹563.20 |
| 2006 | +93.06% | ₹73.45 | ₹141.80 |
| 2005 | +29.98% | ₹56.51 | ₹73.45 |
| 2004 | +251.36% | ₹16.08 | ₹56.51 |
| 2003 | +2854.36% | ₹0.54 | ₹16.08 |
Frequently Asked Questions: GLENMARK
What sector is GLENMARK in? ▼
GLENMARK operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has GLENMARK performed historically? ▼
Over 24 years of trading history, GLENMARK has posted gains in 17 years (71% of the time). The best year was 2003 with a +2854.4% return. Past performance does not guarantee future results.
How can I invest in GLENMARK? ▼
You can invest in GLENMARK through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold GLENMARK.
Last updated: 11/1/2026